Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Coronary Atherosclerosis T1-Weighted Characterization (CATCH)

NCT: NCT03504956 · RECRUITING

NCT IDNCT03504956
StatusRECRUITING
Start Date2018-07-30
Completion2027-12-31
SponsorCedars-Sinai Medical Center (OTHER)
First posted
Last updated

Brief Summary

This study proposes to develop an MRI technique named Coronary Atherosclerosis T1-weighed Characterization (CATCH) that will improve the quality and reliability of coronary atherosclerosis evaluation, as well as simplify the scanning process and significantly shorten imaging time compared with conventional imaging methods.

Frequently Asked Questions

What is Coronary Atherosclerosis T1-Weighted Characterization (CATCH)?

Coronary Atherosclerosis T1-Weighted Characterization (CATCH) is a clinical trial registered under NCT03504956. Current status: RECRUITING.

What is the status of NCT03504956?

The current status of NCT03504956 (Coronary Atherosclerosis T1-Weighted Characterization (CATCH)) is: RECRUITING.

When did Coronary Atherosclerosis T1-Weighted Characterization (CATCH) start?

Coronary Atherosclerosis T1-Weighted Characterization (CATCH) started on 2018-07-30.

Related Devices

K172609CSMC Cardiac SuiteCedars-Sinai Medical Center

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑